News

BerGenBio and Oncoinvent, a rising innovator in radiopharmaceutical cancer therapies, announce proposed merger and a fully underwritten rights issue
BerGenBio ASA (OSE: BGBIO) ("BerGenBio" or the "Company") and Oncoinvent ASA (OSE: ONCIN) ("Oncoinvent") announce that they have entered into a merger agreement (the "Agreement") to combine the two ...
Oncology Innovation Just Hit a Turning Point -- Here's What to Watch
Industry analysts now estimate the global oncology drug market could surpass US$900 billion by 2034, fueled by rising demand ...